コンテンツへスキップ
Merck
  • Disruption of dopamine neuron activity pattern regulation through selective expression of a human KCNN3 mutation.

Disruption of dopamine neuron activity pattern regulation through selective expression of a human KCNN3 mutation.

Neuron (2013-11-12)
Marta E Soden, Graham L Jones, Christina A Sanford, Amanda S Chung, Ali D Güler, Charles Chavkin, Rafael Luján, Larry S Zweifel
要旨

The calcium-activated small conductance potassium channel SK3 plays an essential role in the regulation of dopamine neuron activity patterns. Here we demonstrate that expression of a human disease-related SK3 mutation (hSK3Δ) in dopamine neurons of mice disrupts the balance between tonic and phasic dopamine neuron activity. Expression of hSK3Δ suppressed endogenous SK currents, reducing coupling between SK channels and NMDA receptors (NMDARs) and increasing permissiveness for burst firing. Consistent with enhanced excitability of dopamine neurons, hSK3Δ increased evoked calcium signals in dopamine neurons in vivo and potentiated evoked dopamine release. Specific expression of hSK3Δ led to deficits in attention and sensory gating and heightened sensitivity to a psychomimetic drug. Sensory-motor alterations and psychomimetic sensitivity were recapitulated in a mouse model of transient, reversible dopamine neuron activation. These results demonstrate the cell-autonomous effects of a human ion channel mutation on dopamine neuron physiology and the impact of activity pattern disruption on behavior.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ドーパミン 塩酸塩
Sigma-Aldrich
N-メチル-D-アスパラギン酸, ≥98% (TLC), solid
Supelco
ドーパミン 塩酸塩, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Dopamine hydrochloride solution, 1.0 mg/mL in methanol with 5% 1 M HCl (as free base), ampule of 1 mL, certified reference material, Cerilliant®
ドーパミン 塩酸塩, European Pharmacopoeia (EP) Reference Standard